Catalyst Wire Dossier Catalyst Wire Dossier

Post-transplant cyclophosphamide (PTCy)

cyclophosphamide
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Post-transplant cyclophosphamide (PTCy), covering 2024-12-20 to 2025-12-22. Get the full timeline:

Most recent: Clinical Trial Update: PTCy + Sirolimus/VIC-1911 as GVHD Prophylaxis in Myeloablative PBSC Transplantation [Phase 1, Phase 2]

See pricing